15.25
price down icon0.36%   -0.05
 
loading

Warum fällt Myriad Genetics Inc-Aktie (MYGN)?

Wir haben während der Handelssitzung 2024-11-12 einen Rückgang der Aktie Myriad Genetics Inc (MYGN) um 6.59% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!
2023-11-09:

Shares of Myriad Genetics (MYGN) dropped by 8.94% from $17.89 to $16.29 in the trading on Thursday, Novemeber 9, 2023. The reason why MYGN down is due to the announcement of an upsized underwritten public offering of 6,470,588 shares of common stock at $17.00 per share, with expected gross proceeds of approximately $110 million. The company intends to use the net proceeds to repay loans, settle litigation, and support working capital and general corporate purposes. The offering is managed by Goldman Sachs & Co. LLC, Morgan Stanley, and Wells Fargo Securities and is subject to customary closing conditions.

diagnostics_research LH
$239.53
price up icon 0.74%
$167.75
price up icon 0.47%
$130.78
price down icon 0.68%
diagnostics_research WAT
$366.49
price up icon 2.28%
diagnostics_research MTD
$1,183.42
price up icon 1.28%
$408.36
price down icon 1.66%
Kapitalisierung:     |  Volumen (24h):